New biosensors measure toxic drugs in cancer, arthritis, and organ transplant patients

New biosensors measure toxic drugs in cancer, arthritis, and organ transplant patients
Researchers are a step closer to transforming a US$70 billion global diagnostic industry with new designer biosensors that ‘switch on’ colour or electrical responses to drugs used in cancer, arthritis, and organ transplant treatment. Credit: Queensland University of Technology (QUT)

Researchers are a step closer to transforming a US$70 billion global diagnostic industry with new designer biosensors that ‘switch on’ color or electrical responses to drugs used in cancer, arthritis, and organ transplant treatment.

Researchers from the CSIRO-QUT Synthetic Biology Alliance have proven their modular approach to constructing small molecule biosensors— designed to capture biomarkers of choice and produce measurable responses—in collaboration with Clarkson University in the US and Pathology Queensland.

In two separate studies, biosensors were adapted to accurately measure immunosuppressant drugs cyclosporine A, tacrolimus and rapamycin, and anticancer drug methotrexate, which requires close monitoring to reduce toxicity and organ damage.

Lead researcher Professor Kirill Alexandrov said the biosensors had potential to expand by enabling sophisticated tests on cheaper lab equipment and new point-of-care devices.

“Proteins are at the core of a US$70-billion-dollar global diagnostic market that relies heavily on central lab processing,” Professor Alexandrov said.

“Our will enable tests like therapeutic drug monitoring on less sophisticated equipment that you are more likely to find in small, regional or remote labs and hospitals.”

Future tests may also require smaller biological samples with researchers proving a biosensor could accurately measure cyclosporine A levels in one microlitre blood samples.

“With further development, the could lead to a fingerstick test that potentially provides doctors with patient results in 3-5 minutes during a standard consultation,” Professor Alexandrov said.

Professor Alexandrov said protein complexity and fragility made construction and use of protein biosensors difficult, but the helped alleviate the problem and could be adapted to potentially target any small molecule—not just therapeutic drugs.

He said the new proteins were produced by engineered bacteria, altered using recombinant DNA technology to produce artificial switch molecules that were tailored to recognize a particular drug.

“The protein biosensors are ‘switched off’– like an electrical circuit with a missing piece. Only the targeted biochemical in human fluids like blood or saliva can complete the circuit and ‘switch on’ a signal proportional to the amount of biomarker detected,” he said.

When activated, the different protein biosensors produce either a change of color for hue-based readings, or electrochemical current.

Professor Alexandrov said the team experimented with applications using common glucometer technology to develop a cheap, portable, and accurate device.

“Activated electrochemical biosensors broke down glucose and generated electrons as by-products to produce electrical current proportional to the amount of captured ,” he said.

“The Clarkson team also demonstrated the feasibility of multiplexing this technology to detect two different biomarkers at the same time.”

Despite experiment success, Professor Alexandrov said glucometer technology was use-specific, and researchers would need to re-engineer devices and for new clinical uses.

“There are a huge number of parameters to reconcile when building a medical device. It’s incredibly hard and that’s why new diagnostic technologies come to the market very slowly,” he said.

Professor Alexandrov is from the QUT Centre for Genomics and Personalised Health, the QUT Centre for Agriculture and the Bioeconomy, and the QUT Faculty of Science. He said future research would focus on protein biosensor stability, sensitivity, and manufacturability.

Studies validating different biosensor designs have been recently published by Angewandte Chemie (11 October 2021) and Nature Communications (8 December 2021).



More information: Zhong Guo et al, Design of a methotrexate-controlled chemical dimerization system and its use in bio-electronic devices, Nature Communications (2021). DOI: 10.1038/s41467-021-27184-w

Citation: New biosensors measure toxic drugs in cancer, arthritis, and organ transplant patients (2021, December 19) retrieved 6 January 2022 from https://medicalxpress.com/news/2021-12-biosensors-toxic-drugs-cancer-arthritis.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Metta: A peaceful weapon of loving-kindness thumbnail

Metta: A peaceful weapon of loving-kindness

Discover the true unbound and unconditional love of Metta meditation, a 2500-year-old Buddhist practice. Metta has the power to permeate and transform hearts and minds and forms a peaceful weapon against ill thoughts and feelings.  The legend of Metta During his life, the Buddha hosted every year a three-month-long retreat for his devoted followers. On…
Read More
Ministry of Health Suspects the First Omicron Case in Indonesia Came from Nigeria thumbnail

Ministry of Health Suspects the First Omicron Case in Indonesia Came from Nigeria

KASUS pertama omicron di Indonesia memang terdeteksi pada salah satu petugas kebersihan di Wisma Atlet. Padahal, sebelumnya tidak ada kasus positif varian omicron di Indonesia. Oleh karena itu, Kementerian Kesehatan pun melakukan pelacakan asal muasal masuknya virus Covid-19 varian Omicron ke Indonesia. Dari pelacakan tersebut, Kemenkes menyebut virus itu diduga berasal dari warga negara Indonesia…
Read More
Organic tahini sold nationwide recalled over Salmonella contamination thumbnail

Organic tahini sold nationwide recalled over Salmonella contamination

Rushdi Food Industries, an Israeli based manufacturer, is recalling certain Mighty Sesame 10.9-ounce Organic Tahini (Squeezable) because of potential Salmonella contamination.  This recall was initiated when the company received a notification by the FDA and the Ohio Department of Health of the potential presence of Salmonella in this specific lot.   The recalled product was distributed
Read More
Protocol Optimizing Meds for T2D and CVD Pushed Beyond Cardiology Alone thumbnail

Protocol Optimizing Meds for T2D and CVD Pushed Beyond Cardiology Alone

Meeting Coverage > ADA — Endocrinologists urged to pay attention to COORDINATE trial by Elizabeth Short, Staff Writer, MedPage Today June 27, 2023 SAN DIEGO -- Cardiovascular medications were better optimized for patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD) following a multifaceted intervention involving clinician and patient education, the cluster-randomized COORDINATE-Diabetes
Read More
WHO Ethiopia donates medical supplies and equipment, meets with the Regional Health Bureau (RHB) Head, visits Ayder Hospital and inaugurates the new WHO office premises in the Tigray Region thumbnail

WHO Ethiopia donates medical supplies and equipment, meets with the Regional Health Bureau (RHB) Head, visits Ayder Hospital and inaugurates the new WHO office premises in the Tigray Region

On the 3rd and 4th of August 2023, the World Health Organization's (WHO) Ethiopia Country Office head Dr. Nonhlanhla Dlamini WHO representative a.i., and her team visited the Tigray region. The visit's objectives were to handover medical supplies, meet with the Regional Health Bureau Head, visit Ayder Hospital and to officially inaugurate the new WHO
Read More
Index Of News
Consider making some contribution to keep us going. We are donation based team who works to bring the best content to the readers. Every donation matters.
Donate Now

Subscription Form

Liking our Index Of News so far? Would you like to subscribe to receive news updates daily?

Total
0
Share